Thomas J. Lamb – Law Offices of Thomas J. Lamb, P.A.

Drug Injury Watch: Despite Benefits Of Jardiance, There Are Still Safety Concerns

Drug Injury Watch: Despite Benefits Of Jardiance, There Are Still Safety…more
|

Drug Injury Watch: New Blood-Thinner Savaysa Has No Antidote To Reverse Acute Bleeding

Drug Injury Watch: New Blood-Thinner Savaysa Has No Antidote To Reverse Acute…more
|

Drug Injury Watch: Gilenya PML Warning Label Change Made In August 2015

Drug Injury Watch: Gilenya PML Warning Label Change Made In August 2015 SUMMARY: We get some general context on this emerging drug safety issue from this August 4, 2015 Reuters news report, “FDA to revise Novartis’ Gilenya…more
|

Side Effects Blog: FDA May Require New Onglyza Drug Label For Warning About Heart Failure

Side Effects Blog: FDA May Require New Onglyza Drug Label For Warning About Heart Failure SUMMARY : In April 2015 the results of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus…more
|

Side Effects Blog: Federal Court Zofran MDL Motion; Generic Cases Filed In State Courts

Side Effects Blog: Federal Court Zofran MDL Motion; Generic Cases Filed In State Courts SUMMARY: According a motion filed by GlaxoSmithKline (Glaxo) with the U.S. Judicial Panel on Multidistrict Litigation (JPML), as of early…more
|

Side Effects Blog: Invokana Lawsuits Filed While FDA Investigates Side Effects Reports

Side Effects Blog: Invokana Lawsuits Filed While FDA Investigates Side Effects Reports SUMMARY: Invokana -- first available in 2014 -- is part of a new class of diabetes medications called Sodium-Glucose Co-Transporter-2…more
|

Side Effects Blog: Farxiga / Jardiance / Invokana: Ketoacidosis and Kidney Failure

Side Effects Blog: Farxiga / Jardiance / Invokana: Ketoacidosis and Kidney Failure SUMMARY: On June 22, 2015 Health Canada sent a MedEffect email alert about its "Information Update - Forxiga, Invokana: Health Canada begins…more
|

Side Effects Blog: Bayer's Numbers of YAZ / Yasmin Lawsuits and Settlements in April 2015

According To Bayer, In April 2015 There Were 400 Fewer YAZ / Yasmin Lawsuits Pending, 100 More Settlements, And 500 Cases Just Seem To Vanish From Their Radar Now About Six Years Out From When This Beyaz / Safyral / YAZ /…more
|

Drug Injury Watch: Fosamax - Femur Fracture Lawsuits Update: California Verdict For Merck In April 2015 With Two More California Trials Scheduled For July 2015 And October 2015

Drug Injury Watch: Fosamax - Femur Fracture Lawsuits Update: California Verdict For Merck In April 2015 With Two More California Trials Scheduled For July 2015 And October 2015 Federal Court Fosamax MDL Reassigned From Judge…more
|

Drug Injury Watch: Invokana / Farxiga / Jardiance: New Medical Study Finds A History Of Diabetic Ketoacidosis Events Is Associated With Increased Risk of Death

Drug Injury Watch: Invokana / Farxiga / Jardiance: New Medical Study Finds A History Of Diabetic Ketoacidosis Events Is Associated With Increased Risk of Death This Ketoacidosis Side Effect For These New Diabetes Medicines…more
|

Drug Injury Watch: Multiple Myeloma Drug Pomalyst Associated With Side Effects Risks Of Cardiac Failure, Interstitial Lung Disease, And Hepatotoxicity

Drug Injury Watch: Multiple Myeloma Drug Pomalyst Associated With Side Effects Risks Of Cardiac Failure, Interstitial Lung Disease, And Hepatotoxicity In May 2015 The Medicines and Healthcare Products Regulatory Agency In UK…more
|

Drug Injury Watch: Beyaz / Safyral / YAZ / Yasmin: These Drospirenone Containing Birth Control Pills Have A Higher Risk Of Blood Clot Side Effects Than Older Options

Drug Injury Watch: Beyaz / Safyral / YAZ / Yasmin: These Drospirenone Containing Birth Control Pills Have A Higher Risk Of Blood Clot Side Effects Than Older Options New Medical Journal Article Presents "Compelling Evidence"…more
|

Drug Injury Watch: May 2015 Diabetes Drugs - Ketoacidosis Link Warning By FDA Covers Invokana, Farxiga, And Jardiance, With Label Changes Possible

Drug Injury Watch: May 2015 Diabetes Drugs - Ketoacidosis Link Warning By FDA Covers Invokana, Farxiga, And Jardiance, With Label Changes Possible Case Reports Of These Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors…more
|

Drug Injury Watch: Testosterone Injections Or Shots Such As Depo-Testosterone Might Have Higher Risks Of Heart Attacks, Strokes, And Deaths

Drug Injury Watch: Testosterone Injections Or Shots Such As Depo-Testosterone Might Have Higher Risks Of Heart Attacks, Strokes, And Deaths New Medical Research Suggests The Safety Of A Testosterone Drug Might Depend On Its…more
|

SUMMARY: Plavix (clopidogrel) and Effient (prasugrel) are important antiplatelet blood-thinning medicines used to prevent heart attacks, strokes, and other clot-related diseases.

Drug Injury Watch: Long-Term Combined Plavix - Effient Use May Be Associated With An Increased Overall Risk Of Non-Cardiovascular Death Compared To Shorter Therapy Period FDA Drug Safety Communication Issued In November 2014…more
|
Showing 1-15 of 407 Results
|
View per page
Page: of 28
Contact

Lumina Station, Suite 225 1908 Eastwood Road
Wilmington, NC 28403, United States

  • (910) 256-2971
  • (910) 256-2972

Areas of Practice
  • Personal Injury
  • Products Liability
  • Professional Malpractice
  • Toxic Torts
This profile may constitute attorney advertising. Prior results do not guarantee a similar outcome. Any correspondence with this profile holder does not constitute a client/attorney relationship. Neither the content on this profile nor transmissions between you and the profile holder through this profile are intended to provide legal or other advice or to create an attorney-client relationship.

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×